Expressing support for designation of September 2010 as Blood Cancer Awareness Month.

H.R. 2366 Cancer Coverage Parity Act of 2009 S. 488/H.R. 716 - Access to Cancer Clinical Trials Act of 2009 S. 717 - 21st Century Cancer ALERT Act H.RES.1433 - Designation of September 2010 as Blood Cancer Awareness Month

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Stem Cell Research Advancement Act (H.R. 4808) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Electronic Prescription for Controlled Substances

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

H. Res. 1433, Blood Cancer Awareness Month Resolution

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2366, The Cancer Coverage Parity Act S717, The Cancer ALERT Act HRES 1433, Resolution designating September, 2010, Blood Cancer Awareness Month

Client expense: $61,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2366 - Cancer Coverage Parity S 717 -Cancer ALERT Act H Res 1433 - Resolution designating September 2010 as Blood Cancer Awareness Month

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE